Immune Cell–Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune Cell–Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation

Published:2014-03-03 Issue:6 Volume:4 Page:674-687
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Bald Tobias,Landsberg Jennifer,Lopez-Ramos Dorys,Renn Marcel,Glodde Nicole,Jansen Philipp,Gaffal Evelyn,Steitz Julia,Tolba Rene,Kalinke Ulrich,Limmer Andreas,Jönsson Göran,Hölzel Michael,Tüting Thomas

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Signatures for Responses to Checkpoint Blockade in Small-Cell Lung Cancer in Second-Line Therapy Do Not Predict Responses in First-Line Patients;Cancers;2024-08-08

2. Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy;Pharmacological Research;2024-08

3. Injectable Nanocomposite Hydrogels Improve Intraperitoneal Co-delivery of Chemotherapeutics and Immune Checkpoint Inhibitors for Enhanced Peritoneal Metastasis Therapy;ACS Nano;2024-07-15

4. Exploiting temporal aspects of cancer immunotherapy;Nature Reviews Cancer;2024-06-17

5. IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype;Clinical and Experimental Medicine;2024-05-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP